InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
57,805.99
(
-0.15%
)
Post# of 252588
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

drbio45

Send PM Follow Ignore
Followers 36
Posts 3185
Boards Moderated 0
Alias Born 10/18/2003

drbio45

Re: nuggetminer post# 48552

Friday, 06/15/2007 8:53:44 AM

Friday, June 15, 2007 8:53:44 AM

Post# of 252588
Zimulti panel was concerned about depression related to suicidal thoughts.

Cannaboids create the feeling of Euphoria and the "munchies".

A drug to inhibit the munchies might also lead to depression and suicide.

I don't think that is an enormous leap to make when you are considering the approval of a drug that in a clinical trial has this side effect.

If Vioxx taught the anybody anything it is that safety will be a major concern in the minds of people reviewing the risk benefit of a drug.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up